Anatomic Stage IIIA Breast Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Sulanemadlin (DB17285)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03725436ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid TumorsTreatment